Trade names Rhythmy ATC code none Biological half-life 10.5 h | Routes of
administration Oral (tablets) Legal status ℞-only (JP) Molar mass 475.328 g/mol | |
 | ||
AHFS/Drugs.com International Drug Names | ||
Rilmazafone 2
Rilmazafone (リスミー, Rhythmy, previously known as 450191-S) is a water-soluble benzodiazepine prodrug developed in Japan. It has sedative and hypnotic effects. Rilmazafone induces impairment of motor function and has hypnotic properties.
Contents
Rilmazafone has no effects on benzodiazepine receptors itself, but once inside the body is metabolised by aminopeptidase enzymes in the small intestine to form the active benzodiazepine 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo [1,5-a][1,4]benzodiazepine-2-carboxamide.
Rilmazafone 01
References
Rilmazafone Wikipedia(Text) CC BY-SA